
TRIGGER FOR BURNINGGeneral anesthetics excite sensory neurons in the peripheral nervous system. In this mosaic, a neuron is shown with structures of the general gas anesthetics isoflurane (in the upper right) and etomidate (in the lower left). The center spikes indicate that both drugs are pungent, which makes the neurons fire. Humans feel that firing as burning after inhalation.Rosa Linda Miyares, Georgetown University
100….98….97….96….95….
“Relax.
Keep counting,” the anesthesiologist says to the patient, who is having her hip
surgically replaced. “You won’t feel a thing.”
Though
the woman can no longer feel the dull ache in her hip, she can feel a prickly
burning in her arm where a general anesthetic drips intravenously into her
veins. It is a sensation she doesn’t remember the doctor telling her about, she
thinks, as she forces herself to mouth a few more numbers…94 ….93….92….
For
years patients have reported a burning feeling at the site of a general
anesthetic injection, or in the lungs when inhaling gaseous forms of the drugs,
which put a patient into an unconscious sleep. But doctors could not pinpoint
where the pain response originated — until now.
Science
has finally confirmed the patients’ perspectives and identified the
pain-promoting trigger associated with anesthesia. What’s more, they find that some
anesthetics can also increase pain after surgery by adding to swelling of the
tissue being operated on, a team of scientists from Georgetown University in
Washington, D.C., report in the June 23 Proceedings
of the National Academy of Sciences.
The ion
channel protein called TRPA1 is present on sensory neurons, which are located
in most body tissues. Anesthetics activate this protein, also called the
mustard-oil receptor, causing nerves to "fire.” That message tells the
brain that something painful is happening.
“Probably
what is most significant for people to know is that this activation of a pain
channel actually adds to post-surgery inflammation, so what we didn’t know
before was that you could exacerbate swelling of surgery-damaged tissue with
general anesthetics,” says Georgetown neuroscientist Gerard Ahern, who oversaw
the new study, with lead author and Georgetown postdoctoral researcher José Matta.
“I don’t think anyone has ever considered that before.”
Until
now, scientists did not understand the mechanism by which the anesthetics
activate and sensitize pain-response neurons in the peripheral nervous system.
So anesthesiologists have not known how to reduce the drugs’ painful side
effects. The results may lead to development of new anesthetics or increased
use of the few anesthetics that don’t have these pain-inducing side effects.
“Now
that we know the mechanism that triggers these ill side effects … we can get
closer to finding a single agent, a single general anesthetic to use rather
than a bunch of drugs together,” says Tim Hales, a neuropharmocologist at The George
Washington University in Washington,
D.C., who was not involved in the
research. “The fewer drugs we have to administer, the safer it is for the
patient. That single anesthetic is the ultimate, long-term goal.”Feeling the burn
Each
year, more than a hundred million people go under the knife, according to Georgetown University Medical
Center. Doctors have
known for a long time that patients experience burning where general
anesthetics are injected, Ahern says. That is why anesthesiologists typically
give a local anesthetic such as lidocaine to dull that pain. But it does not
always stop the burning. Inhaling gases that cause temporary unconsciousness
can also cause patients to experience a burning in their lungs, he says.

ALL FIRED UPSome general anesthetics, when given, trigger sensory neurons such as these. Anesthetics tell the nervous system to ignore pain during surgery, but can trigger effects that lead to more pain after surgery.Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buc
Still,
general anesthetics make modern surgery possible because they block the memory and
sensation of pain while a patient is under, says University of Wisconsin–Madison
physiologist Mathew Jones, who was not involved in the research. The drugs, he
says, are not designed to reduce pain but make a patient unaware of it by
affecting the central nervous system — the brain and the spinal cord.
Most
general anesthetics have the undesirable side effect of actually causing pain
or irritation when first administered, before the patient goes to sleep,
because they trigger a response in the peripheral nervous system, an extension
of the central nervous system that includes pain receptors. The anesthetics
activate TRPA1 on pain-sensing nerves, the new study confirms.
The
anesthetics that evoke this sensory response of pain and swelling are called
“noxious” or pungent anesthetics. In this case “noxious” means merely that the
anesthetic causes a sensory response. It is the chemical structure of the drug
that determines whether it will excite the pain-receptor nerve cells.
The
new study verifies that the few non-pungent anesthetics that do exist do not
activate the pain sensory neurons. But, Ahern says, the majority of general
anesthetics used worldwide are pungent.
When
the sensory nerve receptors at the injection site are excited, they release
intercellular messengers that tell the body to send extra white blood cells,
and those cells target tissue damaged during surgery. The white blood cells
prevent against infection but also cause swelling and pain.
Ahern
explains that a patient will always have pain and swelling after surgery
because slicing through the tissue already elicits a white blood cell response.
The pungent anesthetic’s activation, however, adds to that white blood cell
response, which increases pain and inflammation at the site of the surgical
incision when the patient wakes up.
Usually
an anesthetic is injected, Ahern explains, “but if surgery lasts beyond five
minutes, the anesthetic is maintained with gas anesthetics, which can add to
the normal swelling caused after surgical damage to the tissue stops.”
Finding the trigger
Ahern
and researchers in his Georgetown
lab wanted to pinpoint this pain-causing mechanism. They decided they would
first test two specific sensory nerve receptors known to react to other
irritants — specifically wasabi, garlic and capsaicin, the chemical that puts
the bite in hot chili peppers. When the chemicals activate the sensory nerve
receptors, humans feel a burning sensation, Ahern says, and “it seemed that the
receptors reacted to pungent anesthetics in the same way.”
By
inserting DNA that codes for the two kinds of sensory neuron proteins into
human embryonic kidney cells, which do not normally have this sensory-coding
genetic material, the team isolated the sensory receptors in a Petri dish. They
watched the specific mechanisms by which the receptors responded to the different
anesthetics.
The
most commonly used, pungent anesthetics, such as the intravenous liquid
propofol and the gas isoflurane, activated a response only from TRPA1. It is a
principal receptor in the pain pathway. The tests clearly showed that TRPA1 is
activated selectively by pungent anesthetics and not by the non-pungent
anesthetics, Matta says.
But
the scientists wanted to make sure that TRPA1 was the same receptor that caused
pain in living animals and possibly humans. To see that it was, the researchers
applied the anesthesia propofol to the inner nose tissue of a group of normal
mice and a group of mice lacking TRPA1 receptors. The normal mice felt the burn
and tried to rub off the anesthetic by furiously wiping their noses in their
cage sawdust. The mutant mice did not react.
To
study whether the TRPA1 receptor also triggered additional inflammation as it
would after surgery, “we tried to mimic a human operation,” Ahern says. The
scientists induced what would be “post-operative swelling” by rubbing mustard
oil onto one ear of the mice. TRPA1, the mustard-oil receptor, naturally
reacted to the oil, causing the mice’s affected ears to puff up. The researchers
measured the enlargement in comparison to the unaffected ear and then
anesthetized the mice with either isoflurane or another anesthetic, called
sevoflurane — a non-pungent anesthetic. Measuring the changes in swelling
showed that isoflurane, the more commonly used anesthetic, added to ear
inflammation. Sevoflurane did not.
Easing the pain
“This
is an elegant study because of the breadth of the testing,” Hales says. “Here we are
seeing what happens with specific neuron receptors in a Petri dish and can also
see what happens in a whole animal and what the behaviors responses are.”
Jones
too was impressed by the detail of the study. “These authors hit the problem at
all levels, which allows them to understand the phenomenon from single molecules
all the way up to animal behavior,” he says. “That’s cool.”
This
work will be cited by others in the area, “including myself,” adds Hales, who
studies general anesthetics. Right now, he says, anesthesiologists use an armamentarium
of different drugs to put a patient under because one cannot do it well enough.
If attention is given to this new work, anesthesiologists will notice it and
might start thinking about what is the best drug to use to induce
unconsciousness and possibly reduce post-operation swelling and pain, he
explains.
But
the scientists agree there is still a lot more to choosing an anesthetic than
just reducing painful side effects. Some of the non-pungent drugs, like
halothane, have other undesirable effects — such as causing cardiac arrhythmias
— or are more expensive, which is the case with sevoflurane. So right now,
Jones says, the anesthesiologist will still have to decide on a case by case
basis, depending on the patient's condition, history and what other drugs might
be on board during the surgery.
By
knowing about this pain-causing mechanism, it may now be possible to avoid certain
general anesthetics’ side effects either by using TRPA1 blockers along with the
drugs or by designing better anesthetics that don't activate TRPA1 in the first
place, both Matta and Jones say.
Although
it seems natural to assume that reducing inflammation will be beneficial, scientists
have learned that this may not always be the case, says Robert Pearce, who
chairs the anesthesiology department at the University of Wisconsin–Madison
and was also not involved in the study. Studying the inflammatory effects of
the different anesthetics in humans and understanding the healing process will
let doctors determine whether the pain of more inflammation is worth it to gain
the benefit of healthier tissue healing, Pearce explains.
“At
the very least, this provides a first-pass screen for whether an anesthetic is
going to be pungent in patients,” Jones says. Knowing whether a general
anesthetic does or does not evoke a response “will save a lot of money, time
and research animals during the drug development process."
Found in: Body & Brain
Please login or register to participate.